Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCollegium Pharmaceutical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.42 | $1.52 | $1.47 |
| Q2 2024 | 1 | $1.49 | $1.49 | $1.49 |
| Q3 2024 | 1 | $1.55 | $1.63 | $1.59 |
| Q4 2024 | 4 | $1.41 | $1.62 | $1.51 |
| Q1 2025 | 2 | $1.44 | $1.69 | $1.57 |
| Q2 2025 | 1 | $1.59 | $1.64 | $1.62 |
| Q3 2025 | 1 | $1.69 | $1.74 | $1.72 |
| Q4 2025 | 1 | $1.73 | $1.78 | $1.76 |
Collegium Pharmaceutical, Inc. Earnings Date And Information
Collegium Pharmaceutical, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $1.61 earnings per share for the quarter, missing analysts' consensus estimates of $1.66 by $0.05. The company had revenue of 159.30 M for the quarter and had revenue of 566.77 M for the year. Collegium Pharmaceutical, Inc. has generated $2 earnings per share over the last year ($1.29 diluted earnings per share) and currently has a price-to-earnings ratio of 10.6. Collegium Pharmaceutical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Collegium Pharmaceutical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | $1.66 | $0.33 | -1.33 | $155.65 M | $159.30 M |
| 08/08/2024 | Q2 2024 | $1.56 | $0.60 | -0.96 | $143.94 M | $145.28 M |
| 05/09/2024 | Q1 2024 | $1.49 | $0.86 | -0.63 | $144.92 M | |
| 02/22/2024 | Q4 2023 | $1.33 | $0.99 | -0.34 | $149.75 M | |
| 11/07/2023 | Q3 2023 | $1.24 | $0.61 | -0.63 | $137.27 M | $136.71 M |
| 08/03/2023 | Q2 2023 | $1.22 | $0.38 | -0.84 | $138.46 M | $135.55 M |
| 05/04/2023 | Q1 2023 | $1.32 | -$0.51 | -1.83 | $144.77 M | |
| 02/23/2023 | Q4 2022 | $1.03 | -$0.21 | -1.24 | $129.62 M | |
| 11/03/2022 | Q3 2022 | $1.22 | $0.01 | -1.21 | $124.38 M | $127.01 M |
| 08/04/2022 | Q2 2022 | $1.31 | -$0.15 | -1.46 | $121.13 M | $123.55 M |
| 05/10/2022 | Q1 2022 | $0.97 | -$0.39 | -1.36 | $83.75 M | |
| 02/24/2022 | Q4 2021 | $1.04 | -$0.73 | -1.77 | $27.36 M | |
| 11/04/2021 | Q3 2021 | $0.95 | $0.23 | -0.72 | $85.06 M | $78.84 M |
| 08/05/2021 | Q2 2021 | $0.34 | $2.06 | 1.72 | $84.61 M | $82.94 M |
| 05/06/2021 | Q1 2021 | $0.42 | $0.45 | 0.03 | $87.72 M | |
| 02/25/2021 | Q4 2020 | $0.39 | $0.20 | -0.19 | $76.27 M | |
| 11/05/2020 | Q3 2020 | $0.41 | $0.33 | -0.08 | $77.45 M | $79.18 M |
| 08/05/2020 | Q2 2020 | $0.31 | $0.23 | -0.08 | $74.42 M | $78.06 M |
| 05/07/2020 | Q1 2020 | $0.41 | $0.01 | -0.4 | $76.51 M | |
| 02/27/2020 | Q4 2019 | -$0.17 | -$0.07 | 0.1 | $74.20 M |
Collegium Pharmaceutical, Inc. Earnings: FAQ's
When is Collegium Pharmaceutical, Inc.'s earnings date?
Collegium Pharmaceutical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
How can I listen to Collegium Pharmaceutical, Inc.'s earnings conference
call?
The conference call for Collegium Pharmaceutical, Inc.'s latest earnings report can be listened to online.
How can I read Collegium Pharmaceutical, Inc.'s conference call transcript?
The conference call transcript for Collegium Pharmaceutical, Inc.'s latest earnings report can be read online.
How much revenue does Collegium Pharmaceutical, Inc. generate each year?
Collegium Pharmaceutical, Inc. (:COLL) has a recorded annual revenue of $566.77 M.
How much profit does Collegium Pharmaceutical, Inc. generate each year?
Collegium Pharmaceutical, Inc. (:COLL) has a recorded net income of $566.77 M. Collegium Pharmaceutical, Inc. has generated $1.6 earnings per share over the last four quarters.
What is Collegium Pharmaceutical, Inc.'s price-to-earnings ratio?
Collegium Pharmaceutical, Inc. (:COLL) has a price-to-earnings ratio of 10.6 and price/earnings-to-growth ratio is -1.16.